DEA Places Cannabinoid Into Schedule II
The Drug Enforcement Administration placed oral solutions containing the cannabinoid dronabinol into Schedule II of the Controlled Substances Act, in an interim final rule (here). Effective March 23, oral solutions containing dronabinol are subject to new registration, labeling, recordkeeping, and import and export requirements. DEA is accepting comments on the rule until April 24.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
(Federal Register 03/23/17)